臺灣結核病實作指引
0.1.0 - ci-build Taiwan, Province of China flag

臺灣結核病實作指引, published by 衛福部疾病管制署. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/omnifhir/tb/ and changes regularly. See the Directory of published versions

Example Observation: 二線藥敏

status: Final

category: Laboratory

code: 二線藥敏報告

subject: 王大明 Male, DoB: 1996-01-01 ( Health Card Number (use: official, ))

effective: 2026-03-16 10:45:00+0800

performer: Organization: identifier = Provider number (use: official, ); type = Healthcare Provider

note:

二線藥敏備註

method: Genotype MTBDRsl

component

code: 二線藥敏-高濃度Kanamycin

value: 敏感

component

code: 二線藥敏-低濃度Kanamycin

value: 敏感

component

code: 二線藥敏-Ofloxacin

value: 敏感

component

code: 二線藥敏-Ethionamide

value: 敏感

component

code: 二線藥敏-p-aminosalicylicacid

value: 敏感

component

code: 二線藥敏-Rifabutin

value: 敏感

component

code: 二線藥敏-Capreomycin

value: 敏感

component

code: 二線藥敏-Ciprofloxacin

value: 敏感

component

code: 二線藥敏-Moxifloxacin

value: 敏感

component

code: 二線藥敏-Gatifloxacin

value: 敏感

component

code: 二線藥敏-Levofloxacin

value: 敏感

component

code: 二線藥敏-Amikacin

value: 敏感

component

code: 二線藥敏-Prothionamide

value: 敏感

component

code: 二線藥敏-Cycloserine

value: 敏感

component

code: 二線藥敏-Terizidone

value: 敏感

component

code: 二線藥敏-Thioacetazone

value: 敏感

component

code: 二線藥敏-Enviomycin

value: 敏感

component

code: 其他二線藥敏

value: 敏感